HMGCS1 and breast carcinoma: This data highlighted the mevalonate precursor enzyme, 3-hydroxy-3-methylglutaryl-CoA synthase 1 (HMGCS1), whose up-regulation is a common transcriptional event in CSC-enriched subpopulations of breast cancer cell lines.